The post ChatGPT picks 2 recession-proof stocks to buy in 2026 appeared on BitcoinEthereumNews.com. Rising recession concerns in the United States are reshapingThe post ChatGPT picks 2 recession-proof stocks to buy in 2026 appeared on BitcoinEthereumNews.com. Rising recession concerns in the United States are reshaping

ChatGPT picks 2 recession-proof stocks to buy in 2026

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Rising recession concerns in the United States are reshaping investor positioning in 2026, as slowing growth, persistent inflation, and geopolitical tensions weigh on the outlook. 

Major Wall Street institutions now estimate a 30% to 40% chance of a downturn over the next year, marking a shift from earlier soft-landing expectations as economic data show signs of strain.

Indeed, markets are reacting to rising risks, with high oil prices and tight Federal Reserve policy threatening growth and increasing volatility. 

As recession concerns build, investors are shifting toward capital preservation, favoring stable, cash-generating companies. 

Against this backdrop, Finbold used OpenAI’s ChatGPT to identify two stocks to hedge against a downturn.

Procter & Gamble (NYSE: PG)

The first is Procter & Gamble (NYSE: PG), a global consumer staples giant whose product portfolio includes essential household items such as cleaning supplies, personal care products, and hygiene goods. 

According to ChatGPT, the company’s resilience stems from the non-discretionary nature of its offerings, which sustain demand even as consumers cut back on optional spending. 

Its scale and brand strength allow it to pass on higher costs through pricing, preserving margins in inflationary environments. 

This stability is reinforced by a decades-long track record of dividend growth, supported by consistent cash generation across economic cycles.

At press time, PG stock was trading at $142, having gained less than 1% year to date.

PG YTD stock price chart. Source: Finbold

Johnson & Johnson (NYSE: JNJ)

In the second spot, ChatGPT selected healthcare giant Johnson & Johnson (NYSE: JNJ). The company has, over the years, emerged as a diversified healthcare leader with exposure to pharmaceuticals, medical devices, and consumer health products. 

The AI model noted that demand for healthcare remains structurally inelastic, providing a steady revenue base regardless of macroeconomic conditions. 

At the same time, Johnson & Johnson’s diversified business model reduces reliance on any single segment, while its strong balance sheet and defensive earnings profile have historically helped cushion volatility during market downturns. 

Its ability to generate reliable income further enhances its appeal in uncertain environments.

At the close of markets on Friday, JNJ stock was trading at $240, having gained over 15% year to date.

JNJ YTD stock price chart. Source: Finbold

Overall, with recession risks building, the emphasis on defensive positioning is becoming more pronounced. 

It is worth noting that while no equity is immune to broad market declines, companies with essential products, durable demand, and consistent income streams are better equipped to navigate periods of economic stress.

Source: https://finbold.com/chatgpt-picks-2-recession-proof-stocks-to-buy-in-2026/

Market Opportunity
Major Logo
Major Price(MAJOR)
$0,06367
$0,06367$0,06367
-0,77%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags: